These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3006897)
1. Studies of angiotensin I converting enzyme: effects of kinins, bacitracin, gamma-aminobutyric and epsilon-aminocaproic acids, and related compounds on substrate binding and catalysis in vitro. Odya CE; Wilgis FP Can J Physiol Pharmacol; 1986 Jan; 64(1):50-4. PubMed ID: 3006897 [TBL] [Abstract][Full Text] [Related]
2. Interactions of kinins with angiotensin I converting enzyme (kininase II). Odya CE; Wilgis FP; Vavrek RJ; Stewart JM Biochem Pharmacol; 1983 Dec; 32(24):3839-47. PubMed ID: 6140924 [TBL] [Abstract][Full Text] [Related]
3. Kallidin and bradykinin metabolism by isolated cerebral microvessels. Bausback HH; Ward PE Biochem Pharmacol; 1988 Aug; 37(15):2973-8. PubMed ID: 3395372 [TBL] [Abstract][Full Text] [Related]
4. Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex. Oshima G; Hiraga Y; Shirono K; Oh-ishi S; Sakakibara S; Kinoshita T Experientia; 1985 Mar; 41(3):325-8. PubMed ID: 2982643 [TBL] [Abstract][Full Text] [Related]
5. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions. Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin I converting enzyme and kinin-hydrolyzing enzymes along the rabbit nephron. Marchetti J; Roseau S; Alhenc-Gelas F Kidney Int; 1987 Mar; 31(3):744-51. PubMed ID: 3033387 [TBL] [Abstract][Full Text] [Related]
7. Construction of a physiologically active photoaffinity probe based on the structure of bradykinin: labelling of angiotensin converting enzyme but not candidate bradykinin receptors on NG108-15 cells. de Vries JG; Phillips E; Snell CR; Snell PH; Webb M J Neurochem; 1989 May; 52(5):1508-16. PubMed ID: 2540273 [TBL] [Abstract][Full Text] [Related]
8. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase. Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002 [TBL] [Abstract][Full Text] [Related]
9. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme. Sheikh IA; Kaplan AP Biochem Pharmacol; 1986 Jun; 35(12):1951-6. PubMed ID: 3013204 [TBL] [Abstract][Full Text] [Related]
10. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme). Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297 [TBL] [Abstract][Full Text] [Related]
12. Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme. Dorer F; Ryan JW; Stewart JM Biochem J; 1974 Sep; 141(3):915-7. PubMed ID: 4377109 [TBL] [Abstract][Full Text] [Related]
13. Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II). Dorer FE; Stewart JM; Ryan JW Experientia; 1978 Nov; 34(11):1436. PubMed ID: 214326 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P. Ward PE; Chow A; Drapeau G Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078 [TBL] [Abstract][Full Text] [Related]
15. A cysteine-type carboxypeptidase, cathepsin X, generates peptide receptor agonists. Nägler DK; Kraus S; Feierler J; Mentele R; Lottspeich F; Jochum M; Faussner A Int Immunopharmacol; 2010 Jan; 10(1):134-9. PubMed ID: 19800993 [TBL] [Abstract][Full Text] [Related]
16. Kinins in humans. Duncan AM; Kladis A; Jennings GL; Dart AM; Esler M; Campbell DJ Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R897-904. PubMed ID: 10749777 [TBL] [Abstract][Full Text] [Related]